company background image
BELL logo

Belluscura AIM:BELL Stock Report

Last Price

UK£0.095

Market Cap

UK£16.0m

7D

-7.3%

1Y

-52.5%

Updated

05 Dec, 2024

Data

Company Financials +

Belluscura plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Belluscura
Historical stock prices
Current Share PriceUK£0.095
52 Week HighUK£0.27
52 Week LowUK£0.07
Beta1.14
11 Month Change-9.52%
3 Month Change-25.49%
1 Year Change-52.50%
33 Year Change-92.40%
5 Year Changen/a
Change since IPO-82.08%

Recent News & Updates

Recent updates

Here's Why We're A Bit Worried About Belluscura's (LON:BELL) Cash Burn Situation

Dec 22
Here's Why We're A Bit Worried About Belluscura's (LON:BELL) Cash Burn Situation

Shareholder Returns

BELLGB Medical EquipmentGB Market
7D-7.3%-1.5%0.7%
1Y-52.5%-3.9%8.7%

Return vs Industry: BELL underperformed the UK Medical Equipment industry which returned -2.9% over the past year.

Return vs Market: BELL underperformed the UK Market which returned 8.6% over the past year.

Price Volatility

Is BELL's price volatile compared to industry and market?
BELL volatility
BELL Average Weekly Movement5.4%
Medical Equipment Industry Average Movement6.3%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.4%
10% least volatile stocks in GB Market2.6%

Stable Share Price: BELL has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: BELL's weekly volatility has decreased from 14% to 5% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201535Bob Raukerwww.belluscura.com

Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

Belluscura plc Fundamentals Summary

How do Belluscura's earnings and revenue compare to its market cap?
BELL fundamental statistics
Market capUK£16.00m
Earnings (TTM)-UK£14.59m
Revenue (TTM)UK£1.42m

11.3x

P/S Ratio

-1.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BELL income statement (TTM)
RevenueUS$1.80m
Cost of RevenueUS$5.37m
Gross Profit-US$3.57m
Other ExpensesUS$15.04m
Earnings-US$18.60m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.11
Gross Margin-197.53%
Net Profit Margin-1,030.73%
Debt/Equity Ratio0%

How did BELL perform over the long term?

See historical performance and comparison